1999
DOI: 10.1016/s1056-8719(99)00026-x
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of asymmetry of agonist concentration–effect curves

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(13 citation statements)
references
References 20 publications
0
13
0
Order By: Relevance
“…Thus, we propose the following methodology when using the operational model: first, to assess the asymmetry of experimental E/[A] curves by comparing the fit of empirical models including asymmetry [3,8]; and, second, to use the operational model expressed by Eqn 15 or 22 depending on whether the curve is asymmetric or symmetric, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, we propose the following methodology when using the operational model: first, to assess the asymmetry of experimental E/[A] curves by comparing the fit of empirical models including asymmetry [3,8]; and, second, to use the operational model expressed by Eqn 15 or 22 depending on whether the curve is asymmetric or symmetric, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…However, a basic assumption therein that is not always verified is whether the resulting curve is symmetrical (Van der Graff and Schoemaker, 1999). In some instances the curves are asymmetrical and this can affect conclusions derived from the analysis.…”
Section: Introductionmentioning
confidence: 99%
“…The data were simulated from the new 5PL function in Equation (3). The current 5PL function in Equation (2) is linked to the re-parameterized 5PL function in Equation (3) To have a broader comparison between the two 5PL forms, simulations on different parameter combinations were conducted.…”
Section: Simulation Studiesmentioning
confidence: 99%
“…Studies show that the similarity test is sensitive to model inadequacy and the distribution of the F-probability is biased upward when one fails to take asymmetry into account [2]. Subtle deviations from symmetrical behavior may be an indicator of receptor heterogeneity and detection of such complexity may provide crucial information about the pharmacological pathway at an early stage of assay characterization study [3]. Ignoring the asymmetry can also lead to inaccurate estimates of important parameters, poor characterization of the pharmacological pathway and the mechanism, and poor inference with respect to drug-receptor interactions [4].…”
Section: Introductionmentioning
confidence: 99%